Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T13:42:33.347Z Has data issue: false hasContentIssue false

Driving performance in adults with ADHD: Results from a randomized, waiting list controlled trial with atomoxetine

Published online by Cambridge University Press:  15 April 2020

E. Sobanski*
Affiliation:
Central Institute of Mental Health, Department of Psychiatry and Psychotherapy, Medical Faculty Mannheim, University of Heidelberg, J 5, 68159Mannheim, Germany
D. Sabljic
Affiliation:
Central Institute of Mental Health, Department of Psychiatry and Psychotherapy, Medical Faculty Mannheim, University of Heidelberg, J 5, 68159Mannheim, GermanyRuprecht-Karls-University Heidelberg, Department of Legal and Traffic Medicine, Voßstr. 2, 69115Heidelberg, Germany
B. Alm
Affiliation:
Central Institute of Mental Health, Department of Psychiatry and Psychotherapy, Medical Faculty Mannheim, University of Heidelberg, J 5, 68159Mannheim, Germany
R.W. Dittmann
Affiliation:
Central Institute of Mental Health Mannheim, Eli Lilly Endowed Chair for Paediatric Psychopharmacology, Department of Child & Adolescent Psychiatry, Medical Faculty Mannheim, University of Heidelberg, J 5, 68159Mannheim, Germany
P.M. Wehmeier
Affiliation:
Central Institute of Mental Health, Department of Child and Adolescent Psychiatry, Medical Faculty Mannheim, University of Heidelberg, J 5, 68159Mannheim, GermanyVitos Hospital for Psychiatry and Psychotherapy, Weilstr. 10, 35789Weilmuenster, Germany
G. Skopp
Affiliation:
Ruprecht-Karls-University Heidelberg, Department of Legal and Traffic Medicine, Voßstr. 2, 69115Heidelberg, Germany
P. Strohbeck-Kühner
Affiliation:
Ruprecht-Karls-University Heidelberg, Department of Legal and Traffic Medicine, Voßstr. 2, 69115Heidelberg, Germany
*
*Corresponding author. Tel.: +49 621 17032852; fax: +49 621 17032855. E-mail address:esther.sobanski@zi-mannheim.de (E. Sobanski).
Get access

Abstract

Purpose:

To investigate effects of a 12-week treatment with atomoxetine (ATX) on driving performance in real traffic, driving-related neuropsychological performance tests and self-evaluation of driving in adult patients with ADHD compared to an untreated control group with ADHD.

Methods:

Parallel group design with an ATX and a waiting list group. At baseline and endpoint patients were evaluated with a standardized on-road driving test (SDBO), a driving-related neuropsychological test battery (Act and React Test System [ART2020]), and subjective measures of driving performance (one-week driving diary, Driver Coping Questionnaire).

Results:

Forty-three of the 64 included patients completed the study (n = 22 ATX, n = 21 controls). Mean intervention period was 11.9 ± 3.0 weeks, mean daily ATX dosage was 71.6 ± 14.9 mg. At endpoint, 60.1% of patients treated with ATX and 0% of waiting list group had reduced ADHD symptoms by greater or equal to 30%. In SDBO, ATX group reduced driving errors in three of four driving performance categories (attention, P < 0.05; risk-related self-control, P < 0.005; driver skills, P < 0.001), number of driving errors remained stable in control group. At endpoint, 47.6% of control group and 18.2% of ATX group (P < 0.05) did not fulfil the driving fitness criteria according to German Guidelines (percentile rank less or equal to 16 in one or more subtests in ART2020). Total number of self-reported critical traffic situations decreased from 12.0 to 6.8 per week in ATX group (P < 0.05) and remained stable in controls by 9.3 and 9.9 at baseline and endpoint (ns). Coping strategies with stressful traffic situations did not change within both groups.

Conclusion:

Our study provides first evidence that treatment with ATX improves driving performance in real traffic in adults with ADHD.

Information

Type
Original article
Copyright
Copyright © European Psychiatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.